FDA On Use Of AI/ML In Drug Development: Five Key Takeaways - Life Sciences, Biotechnology & Nanotechnology

On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled "Using Artificial Intelligence and Machine Learning in the Development...

Related Keywords

United Kingdom ,Canada , ,National Evaluation System ,Development Of Drug ,Pilot Program ,Technology Approaches For New Drugs ,National Institute For Standards ,Cder Ai Steering Committee ,Drug Administration ,Health Canada ,Drug Development ,Model Development ,Artificial Intelligence ,Machine Learning ,Biological Products ,Applications Exist ,Beach Stage ,Growing Its Own Experience ,Innovative Science ,Technology Approaches ,New Drugs ,Model Informed Drug Development ,Evaluation System ,National Institute ,Developing Technical Standards ,Good Machine Learning Practices ,Identified Key Questions ,Led Governance ,Mondaq ,Fda On Use Of Ai Ml In Drug Development Five Key Takeaways ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,Iotechnology Amp Nanotechnology ,